Cargando…
Dose equivalency and efficacy of biosimilar erythropoietin stimulating agents: Data from real clinical practice
Recently, biosimilar erythropoietin stimulating agents become available in Kazakhstan. Important properties of the biosimilar such as dose equivalency to the original medicine (originator) and the ability to maintain hemoglobin target levels remain insufficiently described in many clinical settings....
Autores principales: | Gaipov, Abduzhappar, Issanov, Alpamys, Mursalova, Zhanar, Tulegenova, Nazia, Kakim, Zoya, Baizakov, Mukhit, Tuganbekova, Saltanat, Aljofan, Mohamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287030/ https://www.ncbi.nlm.nih.gov/pubmed/32524766 http://dx.doi.org/10.1002/prp2.594 |
Ejemplares similares
-
Epidemiology of dialysis-treated end-stage renal disease patients in Kazakhstan: data from nationwide large-scale registry 2014–2018
por: Gaipov, Abduzhappar, et al.
Publicado: (2020) -
SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and post-hospital mortality
por: Gaipov, Abduzhappar, et al.
Publicado: (2021) -
Correction to: SARS-CoV-2 PCR-positive and PCR-negative cases of pneumonia admitted to the hospital during the peak of COVID-19 pandemic: analysis of in-hospital and posthospital mortality
por: Gaipov, Abduzhappar, et al.
Publicado: (2021) -
The Prevalence, Incidence, Indications and Outcomes of Peripartum Hysterectomy in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014–2018
por: Aimagambetova, Gulzhanat, et al.
Publicado: (2022) -
Seroprevalence and risk factors for hepatitis B and hepatitis C in three large regions of Kazakhstan
por: Nersesov, Alexander, et al.
Publicado: (2021)